Literature DB >> 8196504

Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorectic tumor-bearing rats.

W T Chance1, A Balasubramaniam, R Dayal, J Brown, J E Fischer.   

Abstract

Hypothalamic concentration of neuropeptide Y was decreased significantly in anorectic tumor-bearing rats, while NPY level was increased significantly in matched carcass weight control rats as compared with freely-feeding controls. In vivo microdialysis of the perifornical hypothalamic area of tumor-bearing rats prior to the development of anorexia revealed no alteration in NPY in dialysates. Following the development of anorexia, however, tumor-bearing rats exhibited significant reduction in NPY concentration in dialysates as compared with either matched carcass weight or freely-feeding control group. These results suggest that hypothalamic NPY concentration and release are decreased selectively in anorectic tumor-bearing rats. Since NPY also elicits less feeding in tumor-bearing rats, dysfunction of hypothalamic NPY feeding mechanisms may be of primary importance in cancer anorexia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8196504     DOI: 10.1016/0024-3205(94)90144-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Regulation of agouti-related protein messenger ribonucleic acid transcription and peptide secretion by acute and chronic inflammation.

Authors:  Jarrad M Scarlett; Xinxia Zhu; Pablo J Enriori; Darren D Bowe; Ayesha K Batra; Peter R Levasseur; Wilmon F Grant; Michael M Meguid; Michael A Cowley; Daniel L Marks
Journal:  Endocrinology       Date:  2008-06-26       Impact factor: 4.736

Review 2.  Sarcopenia versus cancer cachexia: the muscle wasting continuum in healthy and diseased aging.

Authors:  Alexandra Moreira-Pais; Rita Ferreira; Paula A Oliveira; José A Duarte
Journal:  Biogerontology       Date:  2021-07-29       Impact factor: 4.277

3.  Neuropeptide Y and the development of cancer anorexia.

Authors:  W T Chance; A Balasubramaniam; J E Fischer
Journal:  Ann Surg       Date:  1995-05       Impact factor: 12.969

4.  Pathophysiology and treatment of inflammatory anorexia in chronic disease.

Authors:  Theodore P Braun; Daniel L Marks
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-12-17       Impact factor: 12.910

Review 5.  Hypothalamic integration of immune function and metabolism.

Authors:  Ana Guijarro; Alessandro Laviano; Michael M Meguid
Journal:  Prog Brain Res       Date:  2006       Impact factor: 2.453

6.  Impact of TNF-α Inhibitors on Body Weight and BMI: A Systematic Review and Meta-Analysis.

Authors:  Olivia Patsalos; Bethan Dalton; Jenni Leppanen; Mohammad A A Ibrahim; Hubertus Himmerich
Journal:  Front Pharmacol       Date:  2020-04-15       Impact factor: 5.810

Review 7.  Pathophysiology of anorexia in the cancer cachexia syndrome.

Authors:  Chukwuemeka Charles Ezeoke; John E Morley
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-10-27       Impact factor: 12.910

Review 8.  A review of nutrition and dietary interventions in oncology.

Authors:  Ashley Gray; Brian N Dang; Theodore B Moore; Roger Clemens; Peter Pressman
Journal:  SAGE Open Med       Date:  2020-06-01

Review 9.  Neuroendocrine and Behavioral Consequences of Hyperglycemia in Cancer.

Authors:  Juan H Vasquez; Jeremy C Borniger
Journal:  Endocrinology       Date:  2020-05-01       Impact factor: 4.736

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.